Korean J Gynecol Oncol.
2005 Jun;16(2):97-103.
Decreased expression of galectin-3 is associated with the progression of cervical neoplasia
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea. dsbae@smc.samsung.co.kr
- 2Department of Pathology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract
OBJECTIVE
Galectin-3, a member of the beta-galactoside-binding proteins, is an intracellular and extracellular lectin that interacts with intracellular glycoproteins, cell surface molecules and extracellular matrix proteins. Galectin-3 is expressed widely in epithelial and immune cells and the level of expression varies in many cancer cells relative to the normal tissues from which they arise. We investigated whether the expression of galectin-3 is associated with the progression of cervical neoplasia.
METHODS
The galectin-3 expression was evaluated by immunohistochemistry in 90 formalin-fixed paraffin-embedded cervical tissues: 10 normal cervical specimens, 20 low-grade squamous intraepithelial lesions (LSILs), 20 high-grade squamous intraepithelial lesions (HSILs), and 40 invasive squamous cell carcinomas (ISCCs).
RESULTS
The immunohistochemical staining showed that the expression of galectin-3 was strong in all normal cervical squamous epithelia. Staining gradually decreased in accordance with the histopathologic grades from an LSIL to an HSIL and an ISCC (P<0.001). In particular, the expression of galectin-3 was significantly decreased in HSILs (P=0.001) and this down-regulation was more pronounced in ISCCs than normal tissues (P<0.001).
CONCLUSION
These data constitute the first observation that the expression of galectin-3 is down-regulated in cervical cancer tissues and suggest the decreased expression of this galactoside-binding lectin is associated with the progression of cervical neoplasia.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Is the expression of p16INK4A and galectin-3 correlated with disease progression of cervical neoplasia?
- The Galectin 3 Expression in Benign and Malignant Breast Tumor
- VEGF Expression and Angiogenesis in Uterine Cervical Carcinomas
- The Expression of Vascular Endothelial Growth Factor, Kinase Domain Region, and Transforming Growth Factor-beta 1 in Cervical Neoplasia
- Effects of Intermittent Fasting on Splenic Galectin-3 Protein Expression in High-fat Diet-fed Mice
